Illumina Looks To Triple $8M Win For BGI DNA IP Infringement
Illumina urged a California federal judge on Wednesday to order enhanced damages following a jury determining four out of five of the company's patents behind its next-generation genome-sequencing technology are valid...To view the full article, register now.
Already a subscriber? Click here to view full article